Decoding the mechanisms behind second primary cancers

Abstract Second Primary Cancers (SPCs) are defined as cancers that develop either simultaneously or metachronously in the same individual who has been diagnosed with and survived one primary cancer. SPCs exhibit a high incidence rate and represent the primary cause of mortality among survivors of fi...

Full description

Saved in:
Bibliographic Details
Main Authors: Meiyuan Zeng, Anqi Lin, Aimin Jiang, Zhengang Qiu, Hongman Zhang, Shifu Chen, Mingyan Xu, Zaoqu Liu, Quan Cheng, Jian Zhang, Peng Luo
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-025-06151-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585447563329536
author Meiyuan Zeng
Anqi Lin
Aimin Jiang
Zhengang Qiu
Hongman Zhang
Shifu Chen
Mingyan Xu
Zaoqu Liu
Quan Cheng
Jian Zhang
Peng Luo
author_facet Meiyuan Zeng
Anqi Lin
Aimin Jiang
Zhengang Qiu
Hongman Zhang
Shifu Chen
Mingyan Xu
Zaoqu Liu
Quan Cheng
Jian Zhang
Peng Luo
author_sort Meiyuan Zeng
collection DOAJ
description Abstract Second Primary Cancers (SPCs) are defined as cancers that develop either simultaneously or metachronously in the same individual who has been diagnosed with and survived one primary cancer. SPCs exhibit a high incidence rate and represent the primary cause of mortality among survivors of first primary cancers. There is growing concern about the dangers of SPCs. This review summarizes recent studies on the mechanisms of SPCs, including the roles of genomic changes after first primary cancer (FPC) treatments, stromal cell phenotypic and metabolic changes, hormone levels and receptor expression, immunosuppression, aberrant gene methylation, EGFR signaling, and cell-free DNA in SPC development. This comprehensive analysis contributes to elucidating current research trends in SPC mechanisms and enhances our understanding of the underlying pathophysiology. Furthermore, potential applications of intratumoral microbes, single-cell multi-omics, and metabolomics in investigating SPC mechanisms are also discussed, providing new ideas for follow-up studies.
format Article
id doaj-art-b1069ba3d4aa4f108cc77bbbd4848349
institution Kabale University
issn 1479-5876
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-b1069ba3d4aa4f108cc77bbbd48483492025-01-26T12:50:12ZengBMCJournal of Translational Medicine1479-58762025-01-0123111810.1186/s12967-025-06151-9Decoding the mechanisms behind second primary cancersMeiyuan Zeng0Anqi Lin1Aimin Jiang2Zhengang Qiu3Hongman Zhang4Shifu Chen5Mingyan Xu6Zaoqu Liu7Quan Cheng8Jian Zhang9Peng Luo10Department of Oncology, Zhujiang Hospital, Southern Medical UniversityDepartment of Oncology, Zhujiang Hospital, Southern Medical UniversityDepartment of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University)Department of Oncology, The First Affiliated Hospital of Gannan Medical UniversityDepartment of Oncology, Zhujiang Hospital, Southern Medical UniversityHaploX BiotechnologyHaploX BiotechnologyInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Neurosurgery, Xiangya Hospital, Central South UniversityDepartment of Oncology, Zhujiang Hospital, Southern Medical UniversityDepartment of Oncology, Zhujiang Hospital, Southern Medical UniversityAbstract Second Primary Cancers (SPCs) are defined as cancers that develop either simultaneously or metachronously in the same individual who has been diagnosed with and survived one primary cancer. SPCs exhibit a high incidence rate and represent the primary cause of mortality among survivors of first primary cancers. There is growing concern about the dangers of SPCs. This review summarizes recent studies on the mechanisms of SPCs, including the roles of genomic changes after first primary cancer (FPC) treatments, stromal cell phenotypic and metabolic changes, hormone levels and receptor expression, immunosuppression, aberrant gene methylation, EGFR signaling, and cell-free DNA in SPC development. This comprehensive analysis contributes to elucidating current research trends in SPC mechanisms and enhances our understanding of the underlying pathophysiology. Furthermore, potential applications of intratumoral microbes, single-cell multi-omics, and metabolomics in investigating SPC mechanisms are also discussed, providing new ideas for follow-up studies.https://doi.org/10.1186/s12967-025-06151-9Second Primary CancersMechanismsTumorigenesisImmune
spellingShingle Meiyuan Zeng
Anqi Lin
Aimin Jiang
Zhengang Qiu
Hongman Zhang
Shifu Chen
Mingyan Xu
Zaoqu Liu
Quan Cheng
Jian Zhang
Peng Luo
Decoding the mechanisms behind second primary cancers
Journal of Translational Medicine
Second Primary Cancers
Mechanisms
Tumorigenesis
Immune
title Decoding the mechanisms behind second primary cancers
title_full Decoding the mechanisms behind second primary cancers
title_fullStr Decoding the mechanisms behind second primary cancers
title_full_unstemmed Decoding the mechanisms behind second primary cancers
title_short Decoding the mechanisms behind second primary cancers
title_sort decoding the mechanisms behind second primary cancers
topic Second Primary Cancers
Mechanisms
Tumorigenesis
Immune
url https://doi.org/10.1186/s12967-025-06151-9
work_keys_str_mv AT meiyuanzeng decodingthemechanismsbehindsecondprimarycancers
AT anqilin decodingthemechanismsbehindsecondprimarycancers
AT aiminjiang decodingthemechanismsbehindsecondprimarycancers
AT zhengangqiu decodingthemechanismsbehindsecondprimarycancers
AT hongmanzhang decodingthemechanismsbehindsecondprimarycancers
AT shifuchen decodingthemechanismsbehindsecondprimarycancers
AT mingyanxu decodingthemechanismsbehindsecondprimarycancers
AT zaoquliu decodingthemechanismsbehindsecondprimarycancers
AT quancheng decodingthemechanismsbehindsecondprimarycancers
AT jianzhang decodingthemechanismsbehindsecondprimarycancers
AT pengluo decodingthemechanismsbehindsecondprimarycancers